Training program from Virginia Blood Services based on their policy and practices as well as patient demographics for the Central Shenandoah Valley in VA. The emphasis of Data on Harrisonburg, VA and Winchester, VA
Training program from Virginia Blood Services based on their policy and practices as well as patient demographics for the Central Shenandoah Valley in VA. The emphasis of Data on Harrisonburg, VA and Winchester, VA
Training program from Virginia Blood Services based on their policy and practices as well as patient demographics for the Central Shenandoah Valley in VA. The emphasis of Data on Harrisonburg, VA and Winchester, VA
Watch this Webinar to find and plug leaks in your earned revenue and educate yourself on how to optimize the efficiency and profitability of your practice.
https://www.curemd.com/webinar/fixing-rcm-leaks.html
Training program from Virginia Blood Services based on their policy and practices as well as patient demographics for the Central Shenandoah Valley in VA. The emphasis of Data on Harrisonburg, VA and Winchester, VA
Training program from Virginia Blood Services based on their policy and practices as well as patient demographics for the Central Shenandoah Valley in VA. The emphasis of Data on Harrisonburg, VA and Winchester, VA
Watch this Webinar to find and plug leaks in your earned revenue and educate yourself on how to optimize the efficiency and profitability of your practice.
https://www.curemd.com/webinar/fixing-rcm-leaks.html
With patient responsibility becoming an increasing part of clinics AR, you need to make sure you have an effective strategy in place. Learn how to maximize your collections without negatively impacting your relationships with your patients.
Facilitated on ETSU campus in residential halls and academic classes to prospective students the benefits of organ donation and statistics involved with lack of current organ donors.
When you were diagnosed with cancer, you were thrust into the fight of your life. But you may have quickly learned that the greater battle was surviving the hit that your cancer care delivered to your bank account.
You’re not alone. Bankruptcy rates are almost twice as high among cancer patients as the general population.
"Patients diagnosed with cancer may face significant financial stress, owing to income loss and out-of-pocket costs associated with their treatment," says Scott Ramsey, MD, PhD, a healthcare economist and internist at the Fred Hutchinson Cancer Research Center in Seattle, Washington. "On average, bankruptcy rates increased 4-fold within 5 years of diagnosis."
Join Fight Colorectal Cancer for a webinar that will detail what resources exist to help patients navigate the very expensive waters of cancer treatment. You will hear from a person who is on the front lines of the battle: Elaine Martinez, a case manager with the Colorectal CareLine at the Patient Advocate Foundation.
Elaine serves as an active liaison between patients and their insurers, employers and/or creditors to resolve insurance, job retention, and/or debt crisis matters relative to their diagnosis of colorectal cancer. Her responsibilities include: exploring reimbursement levels for prescribed colorectal cancer treatments, researching available clinical trials for this patient population and facilitating enrollment into appropriate patient resource programs for both the uninsured and underinsured colorectal patients.
In this presentation, Alan Birch discussed the role of an Oncology Drug Access Navigator as well as how the role fits into the healthcare team and what they help patients with. He gave a brief overview and history of the role as well as discussing challenges faced by patients and how National Pharmacare may impact it all.
The webinar was followed by an interactive question & answer session.
About the presenter:
Alan Birch is an Oncology Drug Access Navigator at North York General Hospital. He is a member of ODANO, the oncology drug access navigators of Ontario and has been in the role for the last 5 years. Alan is a registered pharmacy technician by background and is also a member of the Ontario College of Pharmacists and Ontario Pharmacist's Association.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
With patient responsibility becoming an increasing part of clinics AR, you need to make sure you have an effective strategy in place. Learn how to maximize your collections without negatively impacting your relationships with your patients.
Facilitated on ETSU campus in residential halls and academic classes to prospective students the benefits of organ donation and statistics involved with lack of current organ donors.
When you were diagnosed with cancer, you were thrust into the fight of your life. But you may have quickly learned that the greater battle was surviving the hit that your cancer care delivered to your bank account.
You’re not alone. Bankruptcy rates are almost twice as high among cancer patients as the general population.
"Patients diagnosed with cancer may face significant financial stress, owing to income loss and out-of-pocket costs associated with their treatment," says Scott Ramsey, MD, PhD, a healthcare economist and internist at the Fred Hutchinson Cancer Research Center in Seattle, Washington. "On average, bankruptcy rates increased 4-fold within 5 years of diagnosis."
Join Fight Colorectal Cancer for a webinar that will detail what resources exist to help patients navigate the very expensive waters of cancer treatment. You will hear from a person who is on the front lines of the battle: Elaine Martinez, a case manager with the Colorectal CareLine at the Patient Advocate Foundation.
Elaine serves as an active liaison between patients and their insurers, employers and/or creditors to resolve insurance, job retention, and/or debt crisis matters relative to their diagnosis of colorectal cancer. Her responsibilities include: exploring reimbursement levels for prescribed colorectal cancer treatments, researching available clinical trials for this patient population and facilitating enrollment into appropriate patient resource programs for both the uninsured and underinsured colorectal patients.
In this presentation, Alan Birch discussed the role of an Oncology Drug Access Navigator as well as how the role fits into the healthcare team and what they help patients with. He gave a brief overview and history of the role as well as discussing challenges faced by patients and how National Pharmacare may impact it all.
The webinar was followed by an interactive question & answer session.
About the presenter:
Alan Birch is an Oncology Drug Access Navigator at North York General Hospital. He is a member of ODANO, the oncology drug access navigators of Ontario and has been in the role for the last 5 years. Alan is a registered pharmacy technician by background and is also a member of the Ontario College of Pharmacists and Ontario Pharmacist's Association.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
2. Patient Services Overview
Autologous Donations are those donations where a Donor is donating towards
their own surgeries in preparation for possible blood loss.
Patient Selected Donations are those donations where a Friend or Family
Member is donating to a specific person’s needs. They need to either have a
matching or compatible blood type.
There may be a Service Fee applied to all Autologous and Patient Selected
donations of $150 per unit to be drawn. This is payable either by Check or by
Credit/Debit Card. Donor Relations may choose to waive this fee in some cases
(so reach out to Julie Miller at 804.213.4186 if you have any questions).
Q47. Are you giving an Autologous or Directed donation today?
Are you giving for your own surgery? Or to a friend and/or family member
3. You said there “may be a Service Fee”…
For all Autologous and Patient Selected Donations, the
donors in question may be assessed a fee of $150 per
unit to be drawn in order to fulfill the prescription.
This is because generally the hospitals “pick-up” the
costs of testing, processing and distribution of these
units. But in this case, the units are tagged for specific
recipients so the donors themselves are required to pay
for these services.
Occasionally, Patient Services/Donor Relations may
waive this service fee. If you have any questions,
please reach out to Julie Miller at 804.213.4186.
4. Processing Payment of “Service
Fees”
You have obtained your unit, and now we need to
collect payment from the donors. Generally we would
like to do this one of two ways – Check made out to
Virginia Blood Services to be forwarded to LaTina
Johnson in Emerywood or via Credit/Debit Card.
To receive approval for Credit/Debit Card payments you
would need to reach out to one of the following (in
order):
1. Michelle Greygor 412.209.7316
2. Laurie Yakemowicz 412.209.7456
3. Joe Simoni 412.209.7380
4. Richelle Brown-Robinson 412.209.7406
5. Carla Clarke 412.209.7329
6. Autologous Donation Scheduling
All Prescriptions for Autologous Donation must
be signed by the Donor’s Physician, if they are
not we are unable to schedule (or phlebotomize)
this donor.
There must be a minimum of 3 Days
(approximately 72 hours) between each donation
and be scheduled no shorter than 5 Days prior to
the anticipated surgery. This is due to regulations
from the FDA.
7. Registration
When registering a Autologous Donor you want to
make sure you register them using an
Autologous/Therapeutic DHF (DS-003A)
You will need to enter a “Hospital Code” for this
DHF in BBCS.
Screening
It is possible to collect a donor weighing less than 110
lbs using SOP 14-104 (i.e. “Adjusted Bag Weight”)
making sure to not the Amount of blood which was
drawn on the Hang Tab.
Minimum Hemoglobin is 11.0 g/dL (Approx. 33%
Hematocrit)
Due to the risk of BACTEREMIA we are unable to
8. Donor Documentation & Shipping/Notification Cards
You will need to complete a Patient Data Flow
Sheet, Shipping, and Notification Cards.
If you are unable to obtain any of the additional
prescribed units from the donor (beyond their
initial donation) – Notify the Physician and then
Complete a shipping notification to make
Hospital Services aware of any changes to the
original order.
9. Autologous Practice
Let’s do a “Role Play”
Autologous Donor.
Typically, we do not get a great
many Autologous Donors any
longer. What many of us will do
is print out the SOP and Walk
through it step by step.
To sign you off for this we will
have a “pretend” donor that you
will screen as if they were a real
donor.
…I Hear them now
10. Patient Selected Donations
A Friend or Family Member that is donating to a specific
person’s needs. They need to either have a matching or
compatible blood type
11. Patient Selected Donors Overview
Donors seeking to donate for another need to be:
On the list provided by the patient and/or their
family
Donating no less than 3-Days prior to the
anticipated Surgery
We require a prescription for the recipient of all
Patient Selected Donations procedures.
Women of childbearing years should not receive
blood from their husbands (or potential father of
their children).
12. Patient Selected Donors Selection
Patient Selected Donations are those donations where a Friend or
Family Member is donating to a specific person’s needs. They need to
either have a matching or compatible blood type.
The family (or donor) will need to provide us with a list of candidates for
donation.
Unlike Autologous Donors who are registered on the
Autologous/Therapeutic DHF (DS-003A), Patient Selected Donors will
need to be registered and screened with the Allogeneic DHF (DS-003).
Even though the donor has been selected by the Patient (or their
family) they still need to:
Meet Allogeneic Donor Criteria
Have a Matching or Compatible Blood Type (as determined by Physician
Prescription) – when in doubt, call the prescribing Physician
If they are seeking to come in before 56-Days to donate, you will need special
approval from Dr. Sheppard.
13. Patient Selected Donations
Procedures
All Documentation to be filled out for an Autologous
Donation must also be completed for a Patient Selected
Donor. [i.e. Patient Data Flow Sheet, Shipping, and
Notification Cards.]; remembering to update the
Notification Card any time that the order changes.
If samples are unable to be collected during the donation
process, collect the samples via SOP 02-308
Occasionally for PSD procedures you will need to use a
Light Blue “Special Request” hang tag; we need these for
the following cases:
If WB, FFP, Cryo or other components are ordered
If special preparations are required
If the unit needs to be processed as a “STAT” unit.
14. PSD Practice
Let’s do a “Role Play” PSD
Donor.
Typically, we do not get a great
many Patient Selected Donors
any longer. What many of us
will do is print out the SOP and
Walk through it step by step.
To sign you off for this we will
have a “pretend” donor that
you will screen as if they were
a real donor.
…I Hear them now